COOPER COMPANIES, INC. COO
Nasdaq · XNAS · stock · Ophthalmic Goods
Chart by TradingView
6/9
Piotroski F — financial health
4.99
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $4.1B | $374.9M | $2.7B | $433.7M | $8.2B |
| 2024 | $3.9B | $392.3M | $2.6B | $288.1M | $8.1B |
| 2023 | $3.6B | $294.2M | $2.4B | $215.0M | $7.6B |
| 2022 | $3.3B | $385.8M | $2.1B | $450.4M | $7.2B |
| 2021 | $2.9B | $2.9B | $2.0B | $524.2M | $6.9B |
| 2020 | $2.4B | $238.4M | $1.5B | $176.2M | $3.8B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Rosebrough Walter M Jr | director | 2026-04-01 | Option exercise | 832 | — |
| WEISS ROBERT S | director | 2026-04-01 | Option exercise | 3,654 | — |
| Rivas Maria | director | 2026-04-01 | Option exercise | 3,322 | — |
| Jay Colleen | director | 2026-04-01 | Option exercise | 3,322 | — |
| Carbone Barbara | director | 2026-04-01 | Option exercise | 3,050 | — |
| MADDEN TERESA S | director | 2026-04-01 | Option exercise | 3,322 | — |
| Lucchese Cynthia L | director | 2026-04-01 | Option exercise | 3,322 | — |
| Kurzius Lawrence Erik | director | 2026-04-01 | Option exercise | 3,322 | — |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 4.99 (safe)
- Working capital / assets 0.08
- Retained earnings / assets 0.617
- EBIT / assets 0.055
- Equity / liabilities 1.983
Source: SEC EDGAR filings · CIK 0000711404 · as of 2025-10-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.